5-Amino-1MQ: Clinical Mechanism, Dossier & Protocols
Small molecule / peptide-adjacent oral compound that selectively inhibits Nicotinamide N-methyltransferase (NNMT), revitalizing cellular metabolism and accelerating adipocyte shrinkage.
🔬 Molecular Architecture & Physical Specifications
⚙️ Primary Mechanism of Action
Inhibits NNMT enzyme in adipose and muscle tissues, increasing intracellular NAD+ and SAM levels, which ramps up basal metabolic rate and inhibits fat cell expansion.
💉 Research Dosage & Reconstitution Standard
Requires pharmaceutical-grade 0.9% benzyl alcohol Bacteriostatic Water to inhibit bacterial replication for multi-dose access.
⚠️ Contraindications & Documented Adverse Effects
Strict Contraindications
- Pregnancy / nursing
- Severe hepatic disease
Documented Side Effects
- Mild insomnia if taken late
- Dry mouth
- Slight jitteriness in sensitive individuals
📚 Peer-Reviewed References & Authoritative Sources
Citations indexed in PubMed, National Center for Biotechnology Information (NCBI), and ClinicalTrials.gov.
Explore Related Research Modules
Access exact dilution guides, syringe unit calculators, and purity certificates for 5-Amino-1MQ.